Clinical trial / 2015
Adding blueberry juice to etanercept treatment improved response rates and reduced side effects in patients with juvenile idiopathic arthritis.
A phase III randomized trial evaluated 201 JIA patients assigned to etanercept alone (50 mg twice weekly), etanercept plus 50 ml blueberry juice daily (ETABJ), or etanercept plus placebo juice (ETAPJ). After a 6-month follow-up, ACR20, ACR50, and ACR70 scores were significantly higher in the ETABJ group than in the other two groups (P < 0.05). Symptoms and side effects—including mental diseases, optic neuritis, weight gain, infection, cutaneous vasculitis, diarrhea, uveitis, and pancytopenia—were significantly reduced or absent in the ETABJ group. Blueberries also decreased IL-1 alpha and beta levels while increasing IL1RA levels.
- Study type
- Randomized controlled trial (Phase III)
- Who was studied
- 201 patients with juvenile idiopathic arthritis (JIA)
- What was measured
- ACR20, ACR50, ACR70 scores, pro-inflammatory cytokines (IL-1 alpha, IL-1 beta, IL1RA), and side effects
THE PAPER
Blueberry Improves the Therapeutic Effect of Etanercept on Patients with Juvenile Idiopathic Arthritis: Phase III Study.
Zhong Y, Wang Y, Guo J, Chu H, Gao Y, Pang L. Tohoku J Exp Med, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.